Cyclophosphamide undergoes biotransformation in the liver, where it is converted into active alkylating metabolites by a mixed-function microsomal oxidase system. These metabolites inhibit the growth of rapidly dividing malignant cells by cross-linking tumor cell DNA.
Cyclophosphamide is well absorbed orally, with a bioavailability exceeding 75%. Following intravenous administration, peak plasma concentrations of metabolites occur within 2 to 3 hours. The elimination half-life of the unchanged drug ranges from 3 to 12 hours. Excretion primarily occurs via metabolites, with 5-25% of the dose eliminated as an unchanged drug in urine. Some metabolites bind to plasma proteins (>60%). No single metabolite has been identified as solely responsible for therapeutic or toxic effects.
While elevated metabolite levels have been observed in patients with renal impairment, there is no consistent evidence of increased clinical toxicity.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Neoclomide, while effective as a standalone treatment for certain malignancies, is more commonly administered in combination or sequence with other antineoplastic drugs. It is often used in the treatment of the following conditions:
Nonmalignant Disease:
In children, Neoclomide can be used to treat biopsy-proven "minimal change" nephrotic syndrome when corticosteroid therapy fails to produce adequate results or causes intolerable side effects. However, it should not be considered first-line therapy and is not indicated for nephrotic syndrome in adults or other renal conditions.
Use only as directed by a registered physician.
Side Effects
Other: Anaphylaxis, SIADH (syndrome of inappropriate antidiuretic hormone secretion), malaise, and asthenia have been reported.
Treats Cancer and nephrotic syndrome (kidney disease).
Neoclomide 50 Tablet contains Cyclophosphamide, an alkylating agent. It damages the DNA of cancer cells, preventing their growth and multiplication. By interfering with the genetic material, Neoclomide 50 Tablet effectively kills cancer cells and slows tumor progression.
Some common side effects include:
If any of these side effects persist or worsen, consult your doctor immediately.
Malignant Diseases (Adults and Children):
Dosages should be adjusted based on tumor response and leukocyte counts. Leukocyte counts as low as 2000 cells/mm³ (short courses) or 3000 cells/mm³ (prolonged therapy) are tolerable if granulocytopenia is not severe.
When used in combination with other cytotoxic drugs, cyclophosphamide dosages may need to be reduced. Dialysis can remove cyclophosphamide and its metabolites. However, there is no clear evidence supporting dose adjustments in patients with renal impairment.
Nonmalignant Diseases (Minimal Change Nephrotic Syndrome in Children):
- Pediatric Patients: The safety profile is similar to that of adults.
- Geriatric Patients: Older patients may be more susceptible to Neoclomide-related toxicities. Dosages should start at the lower end of the range and be adjusted based on response.
Take Neoclomide 50 Tablet as prescribed by your doctor, based on your medical condition and response to therapy. It is important to follow the prescribed dosage and not discontinue the medication unless advised by your physician.
Neoclomide 50 should not be used during pregnancy or while breastfeeding due to potential harm to the baby.
Store below 25°C in a dry location, protected from light and moisture. Do not freeze. Keep out of reach of children.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.